These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 38228667

  • 1. Prognostic significance of pretreatment albumin-bilirubin (ALBI) grade and platelet-albumin-bilirubin (PALBI) grade in patients with small cell lung cancer.
    Kut E, Menekse S.
    Sci Rep; 2024 Jan 16; 14(1):1371. PubMed ID: 38228667
    [Abstract] [Full Text] [Related]

  • 2. Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study.
    Lee SK, Song MJ, Kim SH, Park M.
    PLoS One; 2019 Jan 16; 14(5):e0216173. PubMed ID: 31048923
    [Abstract] [Full Text] [Related]

  • 3. Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades Accurately Predict Overall Survival in High-Risk Patients Undergoing Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma.
    Hansmann J, Evers MJ, Bui JT, Lokken RP, Lipnik AJ, Gaba RC, Ray CE.
    J Vasc Interv Radiol; 2017 Sep 16; 28(9):1224-1231.e2. PubMed ID: 28688815
    [Abstract] [Full Text] [Related]

  • 4. Albumin-bilirubin and platelet-albumin-bilirubin grades for hepatitis B-associated hepatocellular carcinoma in Child-Pugh A patients treated with radical surgery: A retrospective observational study.
    Wu B, Hu X, Jin H, Zhou L, Zhang D, Man Z, Wang Y, Yang S, Pang Q, Liu H, Cui P.
    Medicine (Baltimore); 2019 Oct 16; 98(43):e17394. PubMed ID: 31651841
    [Abstract] [Full Text] [Related]

  • 5. Albumin-bilirubin index and platelet-albumin-bilirubin index contribute to identifying survival benefit candidates in patients with hepatocellular carcinoma and Child-Pugh grade A undergoing transcatheter arterial chemoembolization with sorafenib treatment.
    Hu K, Yuan J, Tang B, Zhang F, Lu S, Chen R, Zhang L, Ren Z, Yin X.
    Ann Transl Med; 2021 Feb 16; 9(3):237. PubMed ID: 33708864
    [Abstract] [Full Text] [Related]

  • 6. ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era.
    Liu PH, Hsu CY, Hsia CY, Lee YH, Chiou YY, Huang YH, Lee FY, Lin HC, Hou MC, Huo TI.
    J Gastroenterol Hepatol; 2017 Apr 16; 32(4):879-886. PubMed ID: 27696519
    [Abstract] [Full Text] [Related]

  • 7. ALBI and PALBI Grades Are Associated with the Outcome of Patients with Stable Decompensated Cirrhosis.
    Oikonomou T, Goulis L, Doumtsis P, Tzoumari T, Akriviadis E, Cholongitas E.
    Ann Hepatol; 2019 Apr 16; 18(1):126-136. PubMed ID: 31113581
    [Abstract] [Full Text] [Related]

  • 8. Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades Do Not Predict Survival After Transjugular Intrahepatic Portosystemic Shunt Creation.
    Khabbaz RC, Lokken RP, Chen YF, Lipnik AJ, Bui JT, Ray CE, Gaba RC.
    Cardiovasc Intervent Radiol; 2018 Jul 16; 41(7):1029-1034. PubMed ID: 29516241
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of platelet-albumin-bilirubin (PALBI), albumin-bilirubin (ALBI), and child-pugh (CP) score for predicting of survival in advanced hcc patients receiving radiotherapy (RT).
    Ho CHM, Chiang CL, Lee FAS, Choi HCW, Chan JCH, Yeung CSY, Huang JJ, Chan MKH, Blanck O, Wong FCS.
    Oncotarget; 2018 Jun 22; 9(48):28818-28829. PubMed ID: 29988960
    [Abstract] [Full Text] [Related]

  • 11. Comparison of albumin-bilirubin grade, platelet-albumin-bilirubin grade and Child-Turcotte-Pugh class for prediction of survival in patients with large hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation.
    Ni JY, Fang ZT, An C, Sun HL, Huang ZM, Zhang TQ, Jiang XY, Chen YT, Xu LF, Huang JH.
    Int J Hyperthermia; 2019 Jun 22; 36(1):841-853. PubMed ID: 31452408
    [Abstract] [Full Text] [Related]

  • 12. Preoperative platelet-albumin-bilirubin grades predict the prognosis of patients with hepatitis B virus-related hepatocellular carcinoma after liver resection: A retrospective study.
    Luo HM, Zhao SZ, Li C, Chen LP.
    Medicine (Baltimore); 2018 Mar 22; 97(12):e0226. PubMed ID: 29561452
    [Abstract] [Full Text] [Related]

  • 13. Albumin-Based Liver Reserve Models vs. MELD 3.0 in Prognostic Prediction for Hepatocellular Carcinoma Patients with Renal Insufficiency.
    Ho SY, Liu PH, Hsu CY, Tseng HT, Huang YH, Su CW, Hou MC, Huo TI.
    Int J Mol Sci; 2023 Nov 30; 24(23):. PubMed ID: 38069310
    [Abstract] [Full Text] [Related]

  • 14. Prognostic significance of postoperative change of PALBI grade for patients with hepatocellular carcinoma after hepatectomy.
    Wang ZX, Peng W, Zhang XY, Wen TF, Li C.
    Medicine (Baltimore); 2021 Mar 19; 100(11):e24476. PubMed ID: 33725934
    [Abstract] [Full Text] [Related]

  • 15. Assessment in the Survival Outcome After Transarterial Chemoembolization Combined with Cryoablation for Hepatocellular Carcinoma (Diameter > 4cm) Based on the Albumin-Bilirubin Grade and Platelet-Albumin-Bilirubin ‎grade: ‎ A Preliminary Study.
    Huang Z, Zuo M, Ni J, Gu Y, Zhang T, Jiang Y, Zhuo S, An C, Huang J.
    Cancer Manag Res; 2020 Mar 19; 12():1373-1385. PubMed ID: 32158269
    [Abstract] [Full Text] [Related]

  • 16. Application of the Albumin-Bilirubin Grade in Predicting the Prognosis of Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
    Xu L, Wu J, Lu W, Yang C, Liu H.
    Transplant Proc; 2019 Dec 19; 51(10):3338-3346. PubMed ID: 31732203
    [Abstract] [Full Text] [Related]

  • 17. Combination of albumin-bilirubin grade and clinically significant portal hypertension predicts the prognosis of patients with hepatocellular carcinoma after liver resection.
    Qin L, Li C, Xie F, Wang Z, Wen T.
    Biosci Trends; 2021 Mar 15; 15(1):41-49. PubMed ID: 33627573
    [Abstract] [Full Text] [Related]

  • 18. Baseline Albumin-Bilirubin grade as a predictor of response and outcome of regorafenib therapy in patients with hepatocellular carcinoma: a systematic review and meta-analysis.
    Xu H, Cao D, Zhou D, Zhao N, Tang X, Shelat VG, Samant H, Satapathy SK, Tustumi F, Aprile G, He A, Xu X, Ge W.
    BMC Cancer; 2023 Oct 19; 23(1):1006. PubMed ID: 37858207
    [Abstract] [Full Text] [Related]

  • 19. Albumin-bilirubin grade as a predictor of survival in hepatocellular carcinoma patients with thrombocytopenia.
    Man ZR, Gong XK, Qu KL, Pang Q, Wu BQ.
    World J Gastrointest Oncol; 2024 May 15; 16(5):1763-1772. PubMed ID: 38764822
    [Abstract] [Full Text] [Related]

  • 20. Optimizing Prognostic Precision in Hepatocellular Carcinoma: Integrating PWR with ALBI and PALPI Scores.
    Elsabaawy M, Badran H, Ragab A, Abuamer A, Samir T, Zayed E, Ouda A.
    Asian Pac J Cancer Prev; 2024 Sep 01; 25(9):3067-3072. PubMed ID: 39342584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.